Boothbay Fund Management LLC Cuts Stake in Definitive Healthcare Corp. (NASDAQ:DH)

Boothbay Fund Management LLC cut its holdings in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 47.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 382,525 shares of the company's stock after selling 341,971 shares during the period. Boothbay Fund Management LLC owned 0.33% of Definitive Healthcare worth $1,572,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Barclays PLC raised its position in shares of Definitive Healthcare by 318.8% during the 3rd quarter. Barclays PLC now owns 81,916 shares of the company's stock valued at $366,000 after buying an additional 62,354 shares in the last quarter. 272 Capital LP raised its position in Definitive Healthcare by 74.8% during the third quarter. 272 Capital LP now owns 1,114,080 shares of the company's stock valued at $4,980,000 after purchasing an additional 476,766 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of Definitive Healthcare by 431.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 222,090 shares of the company's stock valued at $993,000 after purchasing an additional 180,323 shares during the last quarter. Hennion & Walsh Asset Management Inc. lifted its stake in shares of Definitive Healthcare by 34.1% in the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 50,886 shares of the company's stock valued at $209,000 after purchasing an additional 12,946 shares during the last quarter. Finally, Nisa Investment Advisors LLC increased its position in shares of Definitive Healthcare by 3,652.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company's stock valued at $29,000 after purchasing an additional 6,794 shares during the last quarter. 98.67% of the stock is currently owned by institutional investors.

Definitive Healthcare Trading Up 3.3 %

DH stock traded up $0.09 during mid-day trading on Friday, reaching $2.84. The company had a trading volume of 369,226 shares, compared to its average volume of 851,673. The firm has a 50 day moving average of $2.83 and a 200 day moving average of $3.94. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. Definitive Healthcare Corp. has a 12 month low of $2.15 and a 12 month high of $7.47. The company has a market capitalization of $306.61 million, a PE ratio of -0.92, a price-to-earnings-growth ratio of 4.06 and a beta of 1.48.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.04). Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. The firm had revenue of $62.29 million for the quarter, compared to analysts' expectations of $60.60 million. On average, equities analysts predict that Definitive Healthcare Corp. will post 0.16 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on DH shares. The Goldman Sachs Group lowered their price target on Definitive Healthcare from $4.50 to $3.00 and set a "neutral" rating for the company in a research report on Tuesday, March 4th. Barclays lowered their target price on shares of Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating for the company in a report on Monday, March 3rd. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat.com, Definitive Healthcare has a consensus rating of "Hold" and a consensus target price of $5.35.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.